University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

VuEssence

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Diagnostic

Therapeutic Areas

Neuroscience

Therapeutic Indications

Stroke

Funding Stage

Pre-Seed

Founders

Maha Sallam

Website

https://www.vuessence.com

VuEssence develops molecular diagnostic solutions for stroke, using gene expression blood tests and machine learning to help clinicians assess patients with suspected stroke. [1]

The company was founded in 2010 by Maha Sallam, who serves as president, and is based in Odessa, Florida. It is working toward a blood test that returns stroke-specific gene expression results in under 15 minutes, with a long-term goal of a portable device for ambulances. It has worked with USF Health Neurology on a pilot study of its stroke test. [2]

Discover More with AI